Cyclin B1 expression and p53 status in squamous cell carcinomas of the head and neck

Anticancer Research

Volumn 31, Issue 10, 2011, Pages 3151-3157

  Hoffmann, Thomas K ^a   Trellakis, Sokratis ^a   Okulicz, Kornelia ^a,b   Schuler, Patrick ^a   Greve, Jens ^a   Arnolds, Udith ^a   Bergmann, Christoph ^a   Bas, Murat ^c   Lang, Stephan ^a   Lehnerdt, Götz ^a   Brandau, Sven ^a   Mattheis, Stefan ^a   Scheckenbach, Kathrin ^b   Finn, Oliviera J ^d   Whiteside, Theresa L ^e   Sonkoly, Enikö ^f  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cell cycle; Cyclin B1; Head and neck cancer; p53; Squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN B1; PROTEIN P53;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENERAL PATHOLOGICAL PARAMETERS; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUCOSA; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STAINING; TUMOR RECURRENCE; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN B1; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80054771419     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Nurse P: Universal control mechanism regulating onset of M-phase. Nature 344: 503-508, 1990.
2. Hunt T: Cyclins and their partners: from a simple idea to complicated reality. Seminars in cell biology 2: 213-222, 1991.
3. Shen M, Feng Y, Gao C, Tao D, Hu J, Reed E, Li QQ and Gong J: Detection of cyclin B1 expression in G(1)-phase cancer cell lines and cancer tissues by postsorting Western blot analysis. Cancer Res 64: 1607-1610, 2004. (Pubitemid 38428680)
4. Kawamoto H, Koizumi H and Uchikoshi T: Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses. Am J Pathol 150: 15-23, 1997. (Pubitemid 27027091)
5. Kushner J, Bradley G, Young B and Jordan RC: Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma. J Oral Pathol Med 28: 77-81, 1999. (Pubitemid 29064508)
6. Mashal RD, Lester S, Corless C, Richie JP, Chandra R, Propert KJ and Dutta A: Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res 56: 4159-4163, 1996. (Pubitemid 26305010)
7. Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK and Mao L: Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res 60: 4000-4004, 2000. (Pubitemid 30636572)
8. Wang A, Yoshimi N, Ino N, Tanaka T and Mori H: Overexpression of cyclin B1 in human colorectal cancers. J Cancer Res Clin Oncol 123: 124-127, 1997. (Pubitemid 27062538)
9. Argiris A, Karamouzis MV, Raben D and Ferris RL: Head and neck cancer. Lancet 371: 1695-1709, 2008. (Pubitemid 351671886)
10. Marur S and Forastiere AA: Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clinic Proc 83: 489-501, 2008. (Pubitemid 351536473)
11. Molinolo AA, Amornphimoltham P, Squarize CH, Castilho RM, Patel V and Gutkind JS: Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol 45: 324-334, 2009.
12. Balz V, Scheckenbach K, Gotte K, Bockmuhl U, Petersen I and Bier H: Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens. Cancer Res 63: 1188-1191, 2003. (Pubitemid 36348693)
13. Hoffmann TK, Sonkoly E, Hauser U, van Lierop A, Whiteside TL, Klussmann JP, Hafner D, Schuler P, Friebe-Hoffmann U, Scheckenbach K, Erjala K, Grenman R, Schipper J, Bier H and Balz V: Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma. Oral Oncol 44: 1100-1109, 2008.
14. Koch WM, Brennan JA, Zahurak M, Goodman SN, Westra WH, Schwab D, Yoo GH, Lee DJ, Forastiere AA and Sidransky D: p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J Natl Cancer Inst 88: 1580-1586, 1996. (Pubitemid 26374511)
15. Somers KD, Merrick MA, Lopez ME, Incognito LS, Schechter GL and Casey G: Frequent p53 mutations in head and neck cancer. Cancer Res 52: 5997-6000, 1992.
16. 2/M transition by p53. Oncogene 20: 1803-1815, 2001.
17. Dong Y, Sui L, Watanabe Y, Sugimoto K and Tokuda M: Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinoma. Cancer Lett 177: 13-19, 2002. (Pubitemid 34102394)
18. Hassan KA, El-Naggar AK, Soria JC, Liu D, Hong WK and Mao L: Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue. Clin Cancer Res 7: 2458-2462, 2001. (Pubitemid 32751649)
19. Kao H, Marto JA, Hoffmann TK, Shabanowitz J, Finkelstein SD, Whiteside TL, Hunt DF and Finn OJ: Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T-cells. J Exp Med 194: 1313-1323, 2001. (Pubitemid 33055049)
20. 2/M are overexpressed in aneuploid mammary carcinomas. Cytometry 42: 254-260, 2000.
21. Kim JK and Diehl JA: Nuclear cyclin D1: an oncogenic driver in human cancer. J Cell Physiol 220: 292-296, 2009.
22. 1 regulation in human head and neck cancer. Cancer Res 55: 949-956, 1995.
23. Bellacosa A, Almadori G, Cavallo S, Cadoni G, Galli J, Ferrandina G, Scambia G and Neri G: Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clin Cancer Res 2: 175-180, 1996. (Pubitemid 26046501)
24. Kotelnikov VM, Coon JSt, Mundle S, Kelanic S, LaFollette S, Taylor SI, Hutchinson J, Panje W, Caldarelli DD and Preisler HD: Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis. Clin Cancer Res 3: 95-101, 1997. (Pubitemid 27079450)
25. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E and Balm A: Over expression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55: 975-978, 1995.
26. Winters ZE, Hunt NC, Bradburn MJ, Royds JA, Turley H, Harris AL and Norbury CJ: Subcellular localisation of cyclin B, CDC2 and p21 (WAF1/CIP1) in breast cancer. association with prognosis. Eur J Cancer 37: 2405-2412, 2001. (Pubitemid 33097478)
27. Hassan KA, Ang KK, El-Naggar AK, Story MD, Lee JI, Liu D, Hong WK and Mao L: Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma. Cancer Res 62: 6414-6417, 2002. (Pubitemid 35364097)
28. Arduino PG, Carrozzo M, Chiecchio A, Broccoletti R, Tirone F, Borra E, Bertolusso G and Gandolfo S: Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases. J Oral Maxillofac Surg 66: 1570-1579, 2008. (Pubitemid 351970156)
29. Cojocariu OM, Huguet F, Lefevre M and Perie S: Prognosis and predictive factors in head-and-neck cancers. Bull Cancer 96: 369-378, 2009 (in French).
30. Aaltonen K, Amini RM, Heikkila P, Aittomaki K, Tamminen A, Nevanlinna H and Blomqvist C: High cyclin B1 expression is associated with poor survival in breast cancer. Br J Cancer 100: 1055-1060, 2009.
31. Murakami H, Furihata M, Ohtsuki Y and Ogoshi S: Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma. Virchows Arch 434: 153-158, 1999. (Pubitemid 29184993)
32. 2 checkpoint through cyclin B1. Proc Natl Acad Sci USA 96: 2147-2152, 1999.
33. Innocente SA and Lee JM: p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription. FEBS Lett 579: 1001-1007, 2005. (Pubitemid 40248660)
34. Yu M, Zhan Q and Finn OJ: Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53. Mol Immunol 38: 981-987, 2002. (Pubitemid 34496958)